ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,541
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Mo1393 - Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Psychiatric Disorders
Author(s):
David Back
,
Pamela S. Belperio
,
Mark Bondin
,
Francesco Negro
,
Andrew Talal
,
Caroline Park
,
Yang Lei
,
Eric Crown
,
Federico Mensa
,
Fiona Marra
Publication date
Created:
May 2018
Publication date
(Print):
May 2018
Journal:
Gastroenterology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Gastroenterology
Author and article information
Journal
Title:
Gastroenterology
Abbreviated Title:
Gastroenterology
Publisher:
Elsevier BV
ISSN (Print):
00165085
Publication date Created:
May 2018
Publication date (Print):
May 2018
Volume
: 154
Issue
: 6
Page
: S-1192
Article
DOI:
10.1016/S0016-5085(18)33941-6
SO-VID:
beb4b9dc-5007-4423-aebd-5e1ead373c97
Copyright ©
© 2018
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,541
Glecaprevir/pibrentasvir-associated acute liver injury in non-cirrhotic, chronic HCV infection without HBV co-infection
Authors:
M hammami
,
R Aboushaar
,
E Alsabbagh
…
THU-157-Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection
Authors:
Marianne Martinello
,
Chloe Orkin
,
Graham Cooke
…
Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve non‐cirrhotic genotype 1 and 2 HCV patients in a real‐world setting in Japan
Authors:
Ikeda H
See all similar